Mammography: EUSOBI recommendations for women's information

被引:17
作者
Francesco Sardanelli
Thomas H. Helbich
机构
[1] Dipartimento di Scienze Medico-Chirurgiche, Università degli Studi di Milano, Unità di Radiologia, IRCCS Policlinico San Donato, 20097 San Donato Milanese
[2] Department of Radiology, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna
关键词
Breast Cancer; Breast Reconstruction; Breast Density; Screening Mammography; Breast Cancer Mortality;
D O I
10.1007/s13244-011-0127-y
中图分类号
学科分类号
摘要
This paper summarises the basic information to be offered to women who undergo mammography. After a delineation of the general aim of early diagnosis of breast cancer, the main difference between screening mammography and diagnostic mammography is explained. The best time for scheduling mammography in fertile women is defined. The need to bring images and reports from the previous mammogram (and from other recent breast imaging examinations) is highlighted. The technique and procedure of mammography are briefly described with particular attention to discomfort and pain experienced by a fraction of women who undergo the test. Information is given on the recall during a screening program and on the request for further work-up after a diagnostic mammography. The logic of the diagnostic mammography report and of classification systems such as BI-RADS and R1-R5 is illustrated, and brief but clear information is given about the diagnostic performance of the test, with particular reference to interval cancers. Moreover, the breast cancer risk due to radiation exposure from mammography is compared to the reduction in mortality obtained with the test, and the concept of overdiagnosis is presented. Finally, five frequently asked questions are answered. © European Society of Radiology 2011.
引用
收藏
页码:7 / 10
页数:3
相关论文
共 11 条
  • [1] de Koning H.J., Mammographic screening: Evidence from randomized controlled trials, Ann Oncol, 14, pp. 1185-1189, (2003)
  • [2] Feig S.A., Screening mammography controversies: Resolved, partly resolved, and unresolved, Breast J, 11, (2005)
  • [3] Sardanelli F., Boetes C., Borisch B., Et al., Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group, Eur J Cancer, 46, pp. 1296-1316, (2010)
  • [4] Drossaert C.H., Boer H., Seydel E.R., Monitoring women's experiences during three rounds of breast cancer screening: Results from a longitudinal study, J Med Screen, 9, pp. 168-175, (2002)
  • [5] Tornberg S., Kemetli L., Ascunce N., Et al., A pooled analysis of interval cancer rates in six European countries, Eur J Cancer Prev, 19, pp. 87-93, (2010)
  • [6] Corsetti V., Houssami N., Ghirardi M., Et al., Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: Interval breast cancers at 1 year follow-up, Eur J Cancer, 47, pp. 1021-1026, (2011)
  • [7] Yaffe M.J., Mainprize J.G., Risk of radiation-induced breast cancer from mammographic screening, Radiology, 258, pp. 98-105, (2011)
  • [8] Allgood P.C., Warwick J., Warren R.M., Et al., A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality, Br J Cancer, 98, pp. 206-209, (2008)
  • [9] Puliti D., Miccinesi G., Collina N., Effectiveness of service screening: A case-control study to assess breast cancer mortality reduction, Br J Cancer, 99, pp. 423-427, (2008)
  • [10] Biesheuvel C., Barratt A., Howard K., Houssami N., Irwig L., Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: A systematic review, Lancet Oncol, 8, pp. 1129-1138, (2007)